ArticleJournal of cancer research and clinical oncology2025
From controversy to clarity: reimagining the role of CDK4/6 inhibitors in the adjuvant setting- a number needed to treat perspective.
Armando OrlandiPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.